机译:临床前协会评估抗CD3加IL-1联合抗药性在NOD小鼠新发自身免疫性糖尿病逆转中的功效
Departments of Surgery and Immunology, University of Colorado Denver, Aurora, CO;
La Jolla Institute for Allergy and Immunology, La Jolla, CA;
Departments of Surgery and Immunology, University of Colorado Denver, Aurora, CO;
Department of Pathology, University of Florida, Gainesville, FL;
Yale University School of Medicine, New Haven, CT;
Department of Pathology, University of Florida, Gainesville, FL;
La Jolla Institute for Allergy and Immunology, La Jolla, CA;
La Jolla Institute for Allergy and Immunology, La Jolla, CA;
Immune Tolerance Network, University of California, San Francisco, San Fran-cisco, CA;
Immune Tolerance Network, Bethesda, MD;
Department of Pathology, University of Florida, Gainesville, FL;
Yale University School of Medicine, New Haven, CT;
La Jolla Institute for Allergy and Immunology, La Jolla, CA;
JDRF, New York, NY;
Immune Tolerance Network, University of California, San Francisco, San Fran-cisco, CA;
Benaroya Research Institute, Seattle, WA;
机译:NOD小鼠中1型糖尿病的协同逆转与抗CD3和白细胞介素1阻断改善免疫调节的证据
机译:在非肥胖糖尿病小鼠中,抗CD3 F(ab')2治疗逆转的新发糖尿病的主动耐受性诱导和CD1d限制性自然杀伤T细胞的参与。
机译:由亚致死方法诱导的混合同种异体嵌合体可以预防非肥胖糖尿病(NOD)小鼠的自身免疫性糖尿病并逆转胰岛炎。
机译:预防IL-4和IL-10质粒递送的NOD小鼠自身免疫性糖尿病。
机译:在非肥胖糖尿病(NOD)小鼠中,CD62L(L-选择素)的缺乏不会抑制自身免疫性糖尿病的进展。
机译:临床前协会评估抗CD3加IL-1联合抗药性在NOD小鼠新发自身免疫性糖尿病逆转中的功效
机译:在非肥胖糖尿病小鼠中抗CD3 F(ab')2治疗逆转的新发糖尿病的主动耐受和诱导CD1d限制的自然杀伤T细胞的参与。